323
Participants
Start Date
July 31, 2006
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
Quetiapine or Risperidone + Aripiprazole
Tablets, Oral, Quetiapine 400-800 mg/day or Risperidone (4-8 mg/day) + Aripiprazole 2-15 mg/day, Flexible, 16 weeks.
Quetiapine or Risperidone + placebo
Tablets, Oral, Quetiapine 400-800 mg/day or Risperidone (4-8 mg/day) + Placebo, Flexible, 16 weeks.
New York State Psychiatric Institute, New York
Manhattan Psychiatric Center, New York
Behavioral Medical Research Of Staten Island, Staten Island
Richmond Behavioral Associates, Staten Island
Advanced Bio-Behavioral Sciences, Elmsford
The Zucker Hillside Hospital, Glen Oaks
Neurobehavioral Research, Inc., Cedarhurst
Strong Ties Community Support Program, Rochester
Suburban Research Associates, Media
Va Medical Center (116a), Philadelphia
Thomas Jefferson University, Philadelphia
Belmont Center For Comprehensive Treatment, Philadelphia
Cri Worldwide, Llc, Philadelphia
Department Of Veterans Affairs Medical Center, Coatesville
Sheppard Pratt Health System, Baltimore
Duke University Health System, Durham
Behavioral Clinical Research, Inc, North Miami
Vanderbilt University Medical Center, Nashville
Precise Research Centers, Flowood
Saroj B. Brar, M.D., Inc., Cleveland
Midwest Clinical Research Center, Dayton
Indiana University School Of Medicine, Indianapolis
University Of Minnesota, Minneapolis
Alexian Center For Psychiatric Research, Hoffman Estates
Uptown Research Institute, Llc, Chicago
Lsu Health Sciences Center, Shreveport
J. Gary Booker, Md, Shreveport
K & S Professional Research Services, Llc, Little Rock
Medlabs Research Of Houston, Inc., Houston
University Of Texas Health Science Center At San Antonio, San Antonio
University Of Colorado At Denver And Health Sciences Center, Denver
Comprehensive Neuroscience, Inc., Cerritos
California Clinical Trials Medical Group, Paramount
San Fernando Mental Health Center, Granada Hills
Schuster Medical Research Institute, Sherman Oaks
Pacific Clinical Research Medical Group, Upland
California Clinical Trials, San Diego
Sharp Mesa Vista Hospital, San Diego
California Neuropsychopharmacology Clinical Research Inst., San Diego
Atp Clinical Research, Inc., Costa Mesa
Collaborative Neuroscience Network, Inc., Garden Grove
Uci Medical Center, Orange
Department Of Psychiatry And Behavioral Sciences, Stanford
Va Puget Sound Health Care System, Tacoma
Institute Of Living, Hartford
North Suffolk Mental Health Association, Boston
Community Counseling Of Bristol County, Inc. (Ccbc), Taunton
Cri Worldwide, Llc, Clementon
Collaborators (1)
Otsuka America Pharmaceutical
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY